Načítá se...
The influence of subclonal resistance mutations on targeted cancer therapy
Clinical oncology is being revolutionized by the increasing use of molecularly targeted therapies. This paradigm holds great promise for improving cancer treatment; however, allocating specific therapies to the patients who are most likely to derive a durable benefit continues to represent a conside...
Uloženo v:
| Vydáno v: | Nat Rev Clin Oncol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4838548/ https://ncbi.nlm.nih.gov/pubmed/26483300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2015.175 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|